RAYMOND JAMES & ASSOCIATES - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$760,079
-31.6%
68,662
+0.2%
0.00%0.0%
Q2 2023$1,110,572
+45.1%
68,512
+49.0%
0.00%0.0%
Q1 2023$765,417
-13.3%
45,971
-51.0%
0.00%0.0%
Q4 2022$882,350
+209.6%
93,867
-10.4%
0.00%
Q3 2022$285,000
-12.8%
104,728
-7.3%
0.00%
Q2 2022$327,000
-11.9%
113,009
-8.7%
0.00%
Q1 2022$371,000
-41.2%
123,751
-9.8%
0.00%
-100.0%
Q4 2021$631,000
-60.0%
137,215
-45.4%
0.00%0.0%
Q3 2021$1,578,000
+1.5%
251,336
-3.1%
0.00%0.0%
Q2 2021$1,554,000
-38.8%
259,421
-35.4%
0.00%
-66.7%
Q1 2021$2,541,000
+53.8%
401,730
+36.9%
0.00%
+50.0%
Q4 2020$1,652,000
-25.4%
293,381
-22.9%
0.00%
-33.3%
Q3 2020$2,213,000
-19.2%
380,316
+0.1%
0.00%
-25.0%
Q2 2020$2,740,000
+126.1%
380,044
+46.7%
0.00%
+100.0%
Q1 2020$1,212,000
-42.3%
259,058
-1.0%
0.00%
-33.3%
Q4 2019$2,099,000
-8.7%
261,772
-24.1%
0.00%0.0%
Q3 2019$2,300,000
-17.0%
344,992
-0.0%
0.00%
-25.0%
Q2 2019$2,771,000
-15.4%
345,073
+4.7%
0.00%
-20.0%
Q1 2019$3,277,000
+159.3%
329,726
+99.5%
0.01%
+150.0%
Q4 2018$1,264,000
-49.3%
165,269
+15.5%
0.00%
-50.0%
Q3 2018$2,494,000143,1470.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders